Patents by Inventor Kenneth Karlin

Kenneth Karlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dinuclear copper-based and compound and ligand for nucleic acid scission and anticancer treatment
    Publication number: 20050148662
    Abstract: The present invention is related to a novel method for oxidizing or splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a dinuclear copper-based compound of formula I or a naked ligand of Formula II.
    Type: Application
    Filed: November 12, 2002
    Publication date: July 7, 2005
    Inventors: Steven Rokita, Kenneth Karlin, Lei Li, Narasimha Murthy
  • Dinuclear cooper-based compounds and ligamd for nucleic acid scission and anticancer treatment
    Publication number: 20050090479
    Abstract: The present invention is related to a novel method for splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a dinuclear copper-based compound of Formula I or a naked ligand of formula II: (Formula I and II).
    Type: Application
    Filed: November 12, 2002
    Publication date: April 28, 2005
    Inventors: Steven Rokita, Kenneth Karlin, Kristi Humphreys, Lei Li, Narasimha Murthy
  • Trinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
    Publication number: 20050026897
    Abstract: The present invention is related to a novel method for splitting nucleic acids at specific points on a complementary nucleic acid segment using a trinuclear copper-based compound of formula (I). Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a trinuclear copper-based compound of formula (I) or a naked ligand of formula (II).
    Type: Application
    Filed: May 20, 2002
    Publication date: February 3, 2005
    Inventors: Steven Rokita, Kenneth Karlin, Kristi Humphreys